Credit Agricole
NVAX icon

Credit Agricole’s Novavax NVAX Stock Holding History

Credit Agricole’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-120,000
Closed -$977K – 1367
2026
Q1 		$977K Buy
+120,000
New +$1.09M ﹤0.01% 1081
2025
Q1 		$16K Hold
2,500
– – ﹤0.01% 1199
2024
Q4 		$20.1K Hold
2,500
– – ﹤0.01% 1213
2024
Q3 		$31.6K Hold
2,500
– – ﹤0.01% 1173
2024
Q2 		$31.6K Sell
2,500
-20
-0.8% -$201 ﹤0.01% 1017
2024
Q1 		$9.8K Hold
2,520
– – ﹤0.01% 862
2023
Q4 		$12.1K Hold
2,520
– – ﹤0.01% 835
2023
Q3 		$18.2K Hold
2,520
– – ﹤0.01% 829
2023
Q2 		$18.7K Hold
2,520
– – ﹤0.01% 596
2023
Q1 		$17.5K Hold
2,520
– – ﹤0.01% 567
2022
Q4 		$25.9K Hold
2,520
– – ﹤0.01% 568
2022
Q3 		$46K Buy
2,520
+1,000
+66% +$43.3K ﹤0.01% 525
2022
Q2 		$78K Sell
1,520
-6,362
-81% -$330K ﹤0.01% 481
2022
Q1 		$581K Sell
7,882
-1,289
-14% -$115K 0.01% 348
2021
Q4 		$1.31M Buy
9,171
+6,936
+310% +$1.19M 0.02% 277
2021
Q3 		$464K Buy
2,235
+479
+27% +$106K 0.01% 323
2021
Q2 		$373K Sell
1,756
-374
-18% -$68.5K 0.01% 307
2021
Q1 		$386K Buy
2,130
+1,580
+287% +$315K 0.01% 283
2020
Q4 		$61K Buy
550
+500
+1,000% +$53.1K ﹤0.01% 379
2020
Q3 		$5K Hold
50
– – ﹤0.01% 474
2020
Q2 		$4K Sell
50
-7,368
-99% -$282K ﹤0.01% 434
2020
Q1 		$101K Buy
7,418
+7,368
+14,736% +$62.3K 0.01% 284
2019
Q4 		$0 Hold
50
– – ﹤0.01% 568
2019
Q3 		$0 Hold
50
– – ﹤0.01% 595
2019
Q2 		$0 Hold
50
– – ﹤0.01% 511
2019
Q1 		$1K Hold
50
– – ﹤0.01% 462
2018
Q4 		$2K Hold
50
– – ﹤0.01% 449
2018
Q3 		$2K Buy
+50
New +$1.41K ﹤0.01% 421

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Credit Agricole's NVAX Position: Q2 2026 in Review

Credit Agricole sold out of Novavax (NVAX) in Q2 2026, closing a stake of 120,000 shares — an estimated $977K sold.

Credit Agricole first reported a position in NVAX in Q3 2018 and held it in 28 quarters. The position peaked at $1.31M in Q4 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Credit Agricole reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Credit Agricole sold 120,000 Novavax shares in Q2 2026, an estimated $977K.
  • Credit Agricole first reported a position in Novavax in Q3 2018 and held it in 28 quarters.
  • Credit Agricole's Novavax position peaked at $1.31M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.